Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Understanding TREMFYA® (Guselkumab): A Targeted Treatment for Inflammatory Conditions

TREMFYA® is a biologic therapy known as a monoclonal antibody. It works by targeting and blocking interleukin-23 (IL-23), a key player in inflammation. When IL-23 is overactive, it can contribute to chronic diseases of the skin, joints, and digestive tract. By blocking IL-23, this therapy helps reduce inflammation and prevent flare-ups, thereby improving quality of life. [More]